6β-N-Heterocyclic Substituted Naltrexamine Derivative NAP as a Potential Lead to Develop Peripheral Mu Opioid Receptor Selective Antagonists

A 6β-N-heterocyclic substituted naltrexamine derivative, NAP, was proposed as a peripheral mu opioid receptor (MOR) selective antagonist based on the in vitro and in vivo pharmacological and pharmacokinetic studies. To further validate this notion, several functional assays were carried out to fully...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yuan, Yunyun, Stevens, David L., Braithwaite, Amanda, Scoggins, Krista L., Bilsky, Edward J., Akbarali, Hamid I., Dewey, William L., Zhang, Yan
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3395321/
https://ncbi.nlm.nih.gov/pubmed/22683223
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2012.05.075
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires